Cybin Inc N.CYBN

Alternate Symbol(s): CYBN

Healthcare Drug Manufacturers - Specialty & Generic

Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II. It has an intellectual property portfolio in the psychedelic drug development sector with over 30 patents granted and 160 patents pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands and Ireland.

NEO:CYBN - Post by User

Cybin Inc > Looks like back into the 60s

<< Previous

Bullboard Posts

Next >>

Comment by Jim1274on Nov 24, 2020 3:08pm

68 Views

Post# 31962630

RE:RE:RE:Looks like back into the 60s

It's trading in and around the ipo consistently for the last week, given there is no volume, I'd say that a pretty good thing at the moment, it's means there aren't many weak hands holding at this point, apparently it just popped up on ameritrade today aswell so that should help a bit

<< Previous

Bullboard Posts

Next >>

How to trade on the stock market: A beginner’s guide